Literature DB >> 13511635

Intravenous protein-free pyrogen; a powerful fibrinolytic agent in man.

K N VON KAULLA.   

Abstract

Entities:  

Keywords:  FIBRIN; PYROGENS/effects

Mesh:

Substances:

Year:  1958        PMID: 13511635     DOI: 10.1161/01.cir.17.2.187

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

1.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

2.  Studies on enhanced fibrinolytic activity in man.

Authors:  S SHERRY; R I LINDEMEYER; A P FLETCHER; N ALKJAERSIG
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

3.  Effect of endotoxin shock on the clotting mechanism of dogs.

Authors:  H GANS; W KRIVIT
Journal:  Ann Surg       Date:  1960-07       Impact factor: 12.969

4.  [Observations on blood coagulation & fibrinolysis during surgery of the human heart with hypothermia or by means of extracorporeal circulation].

Authors:  K N VON KAULLA; H SWAN; E VON KAULLA
Journal:  Klin Wochenschr       Date:  1958-11-15

5.  Anticoagulant therapy in cerebrovascular disease.

Authors:  J MARSHALL; D A SHAW
Journal:  Proc R Soc Med       Date:  1959-07

6.  Studies on the thrombolytic activity of human plasma.

Authors:  W D SAWYER; A P FLETCHER; N ALKJAERSIN; S SHERRY
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

7.  [On thrombolysis studies on the rabbit with combined nicotinic acid-heparin therapy].

Authors:  S SAILER; O EBER
Journal:  Klin Wochenschr       Date:  1960-06-01

8.  Changes in Blood After Using an Extracorporeal Circulation.

Authors:  A L Bloom
Journal:  Br Med J       Date:  1961-07-01

9.  Thrombolytic Therapy.

Authors: 
Journal:  Br Med J       Date:  1963-06-08

Review 10.  Molecular aspects of endotoxic reactions.

Authors:  A Nowotny
Journal:  Bacteriol Rev       Date:  1969-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.